Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).
about
Autophagic degradation of peroxisomes in mammalsTumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in ratsInteractions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytesIncrease in hepatic catalase and glycerol phosphate dehydrogenase activities on administration of clofibrate and clofenapate to the ratHepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIBThe peroxisome: still a mysterious organelleStructure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liverInduction of hepatic peroxisome proliferation in nonrodent species, including primatesSimultaneous live-imaging of peroxisomes and the ER in plant cells suggests contiguity but no luminal continuity between the two organellesThe large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with triton WR-1339. Improved isolation procedures, automated analysis, biochemical and morphological properties of fractions.Tissue-specific differential induction of duplicated fatty acid-binding protein genes by the peroxisome proliferator, clofibrate, in zebrafish (Danio rerio)A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drugPhthalate esters as peroxisome proliferator carcinogensPeroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensingFibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptorFurther evidence to suggest that microbodies do not exist as individual entities.Lysosomes of the arterial wall. IV. Cytochemical localization of acid phosphatase and catalase in smooth muscle cells and foam cells from rabbit atheromatous aortaMicrobodies in experimentally altered cells. V. Histochemical and cytochemical studies on the livers of rats and acatalasemic (Csb) mice treated with CPIB.Effects of a single dose of cyclophosphamide on various organs in the rat. IV. Electron microscopic study of the renal tubules.Microbodies in experimentally altered cellsMorphogenesis and development of microbodies of hepatocytes of rats during pre- and postnatal growth.Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with CPIBCytochemical localization of peroxidatic activity of catalase in rat hepatic microbodies (peroxisomes).The synthesis and turnover of rat liver peroxisomes. V. Intracellular pathway of catalase synthesis.Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent.Acyl-Coa oxidase and hydratase-dehydrogenase, two enzymes of the peroxisomal beta-oxidation system, are synthesized on free polysomes of clofibrate-treated rat liver.Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferatorParadoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidationRole of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's DiseasePeroxisome degradation in mammals.Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter.Peroxisome-mitochondria interplay and disease.Peroxisome proliferator-activated receptors and hepatitis C virusPeroxisomal oxidation of long chain fatty acids.The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.The function of energy-dependent redox reactions in cell metabolism.Hepatic and renal effects of peroxisome proliferators: biological implications.
P2860
Q26749227-1A816C3F-9755-4379-A654-D981647ED67BQ28328483-87BC36D1-9D6D-478C-974E-5DFC296DEE45Q28361558-7EC74C8B-EDAB-4F9E-9EEE-291DE86C87ECQ28363705-1BD6344C-6925-42C2-ADB4-DFBA5327ACCCQ28364172-F1D9FDD2-CE61-4E71-9A42-ADC0E6A97C76Q28754736-66345E95-D3FB-4669-AB53-27AC039B73A9Q28760223-169104B4-9221-496C-95FC-9B51E0BA2434Q28762326-B9DC31C5-5103-4E3D-B2DE-7D59867877D0Q30541760-B1DC7ECD-6695-4AE0-9BDE-4CF5ED4B572EQ34205999-D8A152AB-C390-408F-A679-F078694B1000Q34331141-0B650E5E-267C-4EE3-BFBD-DA7552FB4D51Q34585642-20F67635-FFE1-4AAC-8DEE-55E7614EB7A7Q34661276-880240BF-8861-4F4E-9CCB-BEB00F2DA6CAQ35036709-5BE41407-C225-4159-AC98-DD140B073F4FQ35098336-405598C5-6E0D-47C6-AF00-597AC4673F5EQ35752132-44FBB792-3711-4483-AA5A-6A7BA496BEE5Q35864612-88E76BAB-EDDA-4A8D-83F2-A8B800888787Q35875138-FD5909F4-9DFF-498F-AAED-9A920435D33FQ36051945-476E68D9-A3A6-47D1-AD54-8E1616416D48Q36101674-A5B35DC3-F597-4007-9DBE-5AC1D968B6A7Q36188529-00CE9FCA-5507-4ED5-8B6D-2AEFAA1F76FDQ36189586-C529F765-DB67-4E01-9052-7430C8C6D768Q36190433-72C82D4F-D7EC-4383-9F1A-624AC750F420Q36190561-754C84C3-637E-4BA0-A5BA-23AF02C8350CQ36191204-2DA69107-1E00-42CA-943A-2FE5CE662988Q36195665-A90FF909-C910-45AA-822B-B1709487CC51Q36199909-00D596E8-E187-434C-8E96-7F29F63D6A01Q36212154-8F75D69B-0511-457B-AD3B-D4E521EAA48EQ36321611-C9F6AFFF-D3EC-40D3-AC94-B800435AA43CQ37040426-5DC5EEEC-7557-4FE8-8E2B-7F692EC56D9AQ37051264-F7179311-D034-4709-99E5-B16447F70944Q37781280-3020187A-BB50-4BDF-BB7A-71EE12B077B6Q37944553-8BF6F828-A94A-4F16-AAFF-A4ABCBA98FFBQ38292537-F52DA2CE-3217-400D-8EA3-679F06C4825FQ38357539-E139FDB3-FED4-4BE2-817C-EFFE1FE87DE1Q38633502-C10FFB30-C39F-47AC-8FC2-D2B54145C648Q39243020-8227D5E6-AF86-4235-A75B-3D44BF545965Q39642120-339BCA1A-9D7F-4341-A321-BA1C1838E9D4Q40291254-BE4366F4-DA32-4194-9028-208E8DEF44F7Q40333556-03B6DBFC-8D3A-4DD7-97F7-73597EF2C82F
P2860
Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年論文
@yue
1966年論文
@zh-hant
1966年論文
@zh-hk
1966年論文
@zh-mo
1966年論文
@zh-tw
1966年论文
@wuu
1966年论文
@zh
1966年论文
@zh-cn
name
Response of hepatic microbodie ...... lorophenoxyisobutyrate (CPIB).
@en
type
label
Response of hepatic microbodie ...... lorophenoxyisobutyrate (CPIB).
@en
prefLabel
Response of hepatic microbodie ...... lorophenoxyisobutyrate (CPIB).
@en
P2860
P356
P1476
Response of hepatic microbodie ...... lorophenoxyisobutyrate (CPIB).
@en
P2093
Azarnoff DL
Svoboda DJ
P2860
P304
P356
10.1083/JCB.30.2.442
P407
P577
1966-08-01T00:00:00Z